Results 121 to 130 of about 1,955 (223)
Correction to: Burosumab in X-linked hypophosphatemia: a profile of its use in the USA [PDF]
Katherine A. Lyseng‐Williamson
openalex +1 more source
Hypophosphatemic Rickets in Patients from Bichoric Biamniotic Twins: A Case Report
Background. X-linked dominant hypophosphatemic rickets (X-linked hypophosphatemia, XLH) is a disease caused by mutations in the PHEX gene (located at the Xp22.1 locus), which encodes an enzyme bound to the cell surface that cleaves the protein phosphate ...
Anna S. Nechaeva +5 more
doaj +1 more source
Burosumab for the treatment of cutaneous-skeletal hypophosphatemia syndrome
Lillian Abebe +13 more
openalex +1 more source
Tertiary hyperparathyroidism is characterized by hypercalcemia resulting from autonomous parathyroid hormone production and usually occurs after a prolonged period of secondary hyperparathyroidism.
Giulia Puliani +12 more
doaj +1 more source
Genetic causes of hypophosphatemia [PDF]
Phosphate is a key component of mineralized tissues and is also part of many organic compounds. Phosphorus homeostasis depends especially upon intestinal absorption, and renal excretion, which are regulated by various hormones, such as PTH, 1,25 ...
Puente Ruiz, Nuria +2 more
core +1 more source
ODP083 Burosumab Treatment for Fibrous dysplasia/McCune-Albright Syndrome with Severe Spine Deformity [PDF]
Tetsuhiko Sato +4 more
openalex +1 more source
X-linked hypophosphatemic rickets (XLH), the most prevalent form of inherited hypophosphatemic rickets, is caused by loss-of-function mutations in the gene encoding phosphate-regulating endopeptidase homolog, X-linked (PHEX). This case series presents 14
Fahad Al-Juraibah +15 more
doaj +1 more source
Dramatic Transformation After Burosumab in a Young Boy With X-linked Hypophosphatemia: A Life-Changing Saga [PDF]
Krishna M. Baradhi
openalex +1 more source
Burosumab in X-linked hypophosphatemia: a profile of its use in the USA [PDF]
Katherine A. Lyseng‐Williamson
openalex +1 more source

